Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion description "[The EGR1 transactivator is overexpressed in prostate cancer, and its expression pattern suggests that EGR1 could potentially regulate a number of steps involved in initiation and progression of prostate cancer, such as mitogenesis, invasiveness, angiogenesis, and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion evidence source_evidence_literature NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion SIO_000772 10984481 NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion wasDerivedFrom befree-20150227 NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_assertion wasGeneratedBy ECO_0000203 NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.
- befree-20150227 importedOn "2015-02-27" NP371220.RACSzm-Nm7K1HypDLi-I_o78Xs8GSYFWeyQeQJ6i_GykY130_provenance.